Table 3.
Comparison of clinicopathological characteristics between patients undergoing SLN biopsy only and completion lymphadenectomy
| Characteristic | SLN Biopsy Only Group (n = 63) | Completion Lymphadenectomy Group (n = 17) | p-value |
|---|---|---|---|
| Age (years, mean ± SD) | 62.3 ± 8.0 | 63.1 ± 7.9 | 0.735 |
| BMI (kg/m², mean ± SD) | 28.8 ± 4.4 | 29.5 ± 4.3 | 0.591 |
| Parity (mean ± SD) | 2.1 ± 1.2 | 1.9 ± 1.4 | 0.610 |
| Postmenopausal, n (%) | 39 (61.9) | 10 (58.8) | 0.802 |
| Histological Type, n (%) | < 0.001 | ||
| Endometrioid | 60 (95.2) | 2 (11.8) | |
| Serous | 1 (1.6) | 10 (58.8) | |
| Other | 2 (3.2) | 5 (29.4) | |
| Tumor Grade, n (%) | < 0.001 | ||
| Grade 1 | 33 (52.4) | 1 (5.9) | |
| Grade 2 | 26 (41.3) | 6 (35.3) | |
| Grade 3 | 4 (6.3) | 10 (58.8) | |
| FIGO Stage, n (%) | 0.002 | ||
| Stage I | 62 (98.4) | 12 (70.6) | |
| Stage II | 1 (1.6) | 5 (29.4) |